The Evolving World of Chronic Kidney Disease Mineral Bone Disorder

The Evolving World of Chronic Kidney Disease Mineral Bone Disorder

Chronic kidney disease – mineral and bone disorder (CKD-MBD) is associated with a significant morbidity and mortality. In vitro and animal models suggest that phosphorous, calcium, parathyroid hormone, and vitamin D abnormalities, mediate the cardiovascular and bone diseases that characterise CKD-MB...

Full description

Bibliographic Details
Main Authors:	Antonio Bellasi, Andrea Galassi, Mario Cozzolino, Biagio Di Lorio
Format:	Article
Language:	English
Published:	European Medical Journal 2013-07-01
Series:	European Medical Journal Nephrology
Subjects:	Chronic Kidney Disease Mineral Bone Disorder CKD-MBD Dialysis Management Needs Outcome
Online Access:	http://emjreviews.com/wp-content/uploads/EMJ-Nephrology-Bellasi-A-et-al..pdf

Similar Items

Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide
by: Cozzolino M, et al.
Published: (2017-06-01)

Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study
by: Te-Hui Kuo, et al.
Published: (2019-07-01)

PATTERNS OF CHRONIC KIDNEY DISEASE – MINERAL BONE DISEASE AND ITS RELATIONSHIP WITH SOCIO-DEMOGRAPHIC FACTORS AMONG THE PATIENTS OF CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS
by: Batool Butt, et al.
Published: (2021-01-01)

Teriparatide Treatment for Hypercalcemia Associated With Adynamic Bone Disease
by: Jennifer Peugh, et al.
Published: (2019-07-01)

Vitamin D Effects on Bone Homeostasis and Cardiovascular System in Patients with Chronic Kidney Disease and Renal Transplant Recipients
by: Giuseppe Cianciolo, et al.
Published: (2021-04-01)

The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i
by: Giuseppe Cianciolo, et al.
Published: (2020-06-01)

Impact of physical activity and exercise on bone health in patients with chronic kidney disease: a systematic review of observational and experimental studies
by: Daniela F. Cardoso, et al.
Published: (2020-08-01)

Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease–Metabolic Bone Disease (CKD-MBD)
by: Mariano Rodriguez, et al.
Published: (2018-12-01)

Modifying Phosphate Toxicity in Chronic Kidney Disease
by: Marc Vervloet
Published: (2019-09-01)

Aortic stenosis is a risk factor for all-cause mortality in patients on dialysis: a multicenter prospective cohort analysis
by: Daijo Inaguma, et al.
Published: (2018-04-01)

Investigation on urinary and serum alpha klotho in dogs with chronic kidney disease
by: Hong jae Yi, et al.
Published: (2020-07-01)

Bone fragility in patients with chronic kidney disease
by: Martine Cohen-Solal, et al.
Published: (2020-04-01)

Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients
by: Kanda Eiichiro, et al.
Published: (2012-09-01)

Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects
by: Jordi Bover, et al.
Published: (2021-05-01)

Alkaline Phosphatases Account for Low Plasma Levels of Inorganic Pyrophosphate in Chronic Kidney Disease
by: Audrey Laurain, et al.
Published: (2020-12-01)

Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
by: Seiji Fukumoto
Published: (2018-02-01)

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide
by: Cernaro V, et al.
Published: (2016-02-01)

A Changing Perspective for Treatment of Chronic Kidney Disease
by: Giacomo Garibotto
Published: (2021-08-01)

Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone Disorder
by: Toshifumi Sugatani
Published: (2018-08-01)

Expression of Circulating MicroRNAs Linked to Bone Metabolism in Chronic Kidney Disease-Mineral and Bone Disorder
by: Maria P. Yavropoulou, et al.
Published: (2020-12-01)

Cardiovascular Risk and Mineral Bone Disorder in Patients with Chronic Kidney Disease
by: Hagen Staude, et al.
Published: (2013-03-01)

Association between Allelic Variations of -174G/C Polymorphism of Interleukin-6 Gene and Chronic Kidney Disease-Mineral and Bone Disorder in Iraqi Patients
by: Mohanad Radeef
Published: (2020-12-01)

Editorial on the Special Issue “Comorbidities in Chronic Kidney Disease”
by: Heidi Noels, et al.
Published: (2020-06-01)

Association between serum fibroblast growth factor‐23 concentration and development of hyperphosphatemia in normophosphatemic dogs with chronic kidney disease
by: Hirosumi Miyakawa, et al.
Published: (2021-09-01)

Strategies for Optimizing Growth in Children With Chronic Kidney Disease
by: Dieter Haffner
Published: (2020-07-01)

Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5
by: Antonio Bellasi, et al.
Published: (2019-07-01)

Clinical Evaluation of the Safety, Efficacy and Tolerability of Lanthanum Carbonate in the Management of Hyperphosphatemia in Patients with End-Stage Renal Disease
by: Cernaro V, et al.
Published: (2020-09-01)

A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism
by: Helen Eddington, et al.
Published: (2021-03-01)

Emerging Effects of Sevelamer in Chronic Kidney Disease
by: Ryota Ikee, et al.
Published: (2013-03-01)

Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism
by: Chihiro Kato, et al.
Published: (2020-10-01)

Bone Biopsy Results in Chronic Kidney Disease: a Single-Center Experience
by: Orfeas Liangos, et al.
Published: (2018-08-01)

Intermittent hemodialysis in dogs with chronic kidney disease stage III
by: Alessandra Melchert, et al.
Published: (2017-08-01)

Sucroferric oxyhydroxide decreases serum phosphorus level and fibroblast growth factor 23 and improves renal anemia in hemodialysis patients
by: Hisato Shima, et al.
Published: (2018-06-01)

The role of fibroblast growth factor-23 in chronic kidney disease-mineral and bone disorder
by: Mirza, Majd A. I.
Published: (2010)

A Role of Intestinal Alkaline Phosphatase 3 (Akp3) in Inorganic Phosphate Homeostasis
by: Shohei Sasaki, et al.
Published: (2018-09-01)

CKD 5D Asia—what is common and what is different from the West?
by: Kunitoshi Iseki
Published: (2018-09-01)

The Importance of Phosphate Control in Chronic Kidney Disease
by: Ken Tsuchiya, et al.
Published: (2021-05-01)

Fibroblast growth factor 23 and cardiovascular disease in patients with chronic kidney disease
by: Kosaku Nitta
Published: (2018-08-01)

The stability and variability of serum and plasma fibroblast growth factor-23 levels in a haemodialysis cohort
by: Matthew J. Damasiewicz, et al.
Published: (2018-11-01)

Uric Acid in Chronic Kidney Disease: A Clinical Appraisal
by: Andrea Galassi, et al.
Published: (2016-07-01)

Cannot write session to /tmp/vufind_sessions/sess_dicbmklclvgadqos0qk0305pdd